Clinical Trials Directory

Trials / Completed

CompletedNCT04077203

Biofeedback of Glucose in Non-diabetic Participants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Klick Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This research examines whether biofeedback of glucose (i.e., knowledge of one's own glucose levels) in non-diabetic participants affects their health behaviours (e.g., eating, nutrition, exercise, etc.). This study utilizes wearable continuous glucose (CGM) technology, which provides personalized feedback to participants to allow them to self-monitor their own glucose levels.

Detailed description

The purpose of this research is to examine whether self-monitoring and biofeedback of glucose levels improves health outcomes in non-diabetic participants. All participants will receive a continuous flash glucose monitor (consisting of an adhesive patch sensor and a handheld reader device) to wear for 14 days. Participants will be randomized into one of 2 groups: those receiving biofeedback (the ability to visualize their glucose levels via the handheld device), and the control group (receiving no biofeedback because the handheld device monitor will be occluded with black tape). Participants' objective and self-report health metrics will be measured before and after the 14-day intervention. The goal is to examine whether the biofeedback condition influences any daily activities or physiological measurements compared to the control condition, as a direct result of self-monitoring glucose levels.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBiofeedback / No biofeedbackBiofeedback / No biofeedback

Timeline

Start date
2019-07-16
Primary completion
2019-11-30
Completion
2019-11-30
First posted
2019-09-04
Last updated
2020-11-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04077203. Inclusion in this directory is not an endorsement.